| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
111,133 |
31,675 |
$1.01M |
| 87186 |
|
60,517 |
39,613 |
$221K |
| 80053 |
Comprehensive metabolic panel |
207,200 |
116,514 |
$216K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
142,443 |
72,719 |
$116K |
| 84443 |
Thyroid stimulating hormone (TSH) |
72,484 |
48,123 |
$105K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
300,594 |
156,338 |
$71K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
32,923 |
22,273 |
$64K |
| 80061 |
Lipid panel |
71,310 |
48,282 |
$47K |
| 83880 |
|
14,158 |
8,024 |
$39K |
| 82652 |
|
10,657 |
7,182 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
84,517 |
56,528 |
$32K |
| 82140 |
|
25,194 |
13,647 |
$30K |
| 80164 |
|
28,882 |
17,923 |
$30K |
| 82607 |
|
28,551 |
19,224 |
$28K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
65,608 |
18,503 |
$28K |
| 81001 |
|
73,348 |
47,142 |
$25K |
| 80177 |
|
16,018 |
10,297 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
83,545 |
53,269 |
$20K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
997 |
653 |
$18K |
| 80202 |
|
6,610 |
1,803 |
$15K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
357,083 |
159,590 |
$14K |
| 87088 |
|
64,330 |
41,520 |
$14K |
| 83970 |
|
3,708 |
2,288 |
$11K |
| 85610 |
|
57,121 |
10,905 |
$9K |
| 84153 |
|
5,671 |
4,009 |
$9K |
| 85027 |
|
41,814 |
24,723 |
$7K |
| 87070 |
|
8,177 |
5,315 |
$7K |
| 82728 |
|
11,496 |
7,637 |
$6K |
| 82746 |
|
15,848 |
10,785 |
$6K |
| 84134 |
|
1,143 |
932 |
$6K |
| 84436 |
|
23,385 |
15,851 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
5,100 |
2,819 |
$5K |
| 80185 |
|
4,922 |
2,532 |
$5K |
| 83735 |
|
20,383 |
12,564 |
$5K |
| 87631 |
|
509 |
322 |
$4K |
| 80076 |
|
12,716 |
8,671 |
$4K |
| 81003 |
|
12,432 |
8,566 |
$4K |
| 84481 |
|
2,522 |
1,641 |
$4K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
1,122 |
637 |
$4K |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
455,586 |
199,059 |
$4K |
| 84479 |
|
17,431 |
11,817 |
$3K |
| 80156 |
|
1,945 |
1,315 |
$3K |
| 82274 |
|
4,899 |
2,632 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
169 |
118 |
$3K |
| 87077 |
|
8,254 |
5,243 |
$2K |
| 80184 |
|
1,612 |
1,090 |
$2K |
| 84466 |
|
4,592 |
3,056 |
$2K |
| 86140 |
|
8,795 |
4,361 |
$2K |
| 87184 |
|
600 |
383 |
$2K |
| 87075 |
|
2,751 |
1,830 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
551 |
334 |
$2K |
| 80162 |
|
3,443 |
2,088 |
$2K |
| 84439 |
|
10,982 |
7,274 |
$2K |
| 85651 |
|
9,495 |
4,786 |
$2K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
106,449 |
55,226 |
$2K |
| 80074 |
|
341 |
248 |
$1K |
| 87045 |
|
2,127 |
1,384 |
$1K |
| 87205 |
|
10,956 |
7,092 |
$1K |
| 85014 |
|
7,910 |
2,872 |
$1K |
| 84480 |
|
4,221 |
2,850 |
$1K |
| 82565 |
|
2,377 |
1,201 |
$1K |
| 83540 |
|
6,326 |
4,221 |
$1K |
| 83550 |
|
5,370 |
3,590 |
$1K |
| 87106 |
|
811 |
551 |
$967.68 |
| 83010 |
|
2,677 |
1,796 |
$688.20 |
| 87040 |
|
1,440 |
602 |
$683.83 |
| 84550 |
|
7,189 |
4,801 |
$637.00 |
| 85018 |
|
8,377 |
3,054 |
$634.86 |
| 80178 |
|
1,343 |
746 |
$620.87 |
| 80069 |
|
923 |
569 |
$572.11 |
| 82040 |
|
2,171 |
1,550 |
$567.12 |
| 84132 |
|
1,998 |
1,078 |
$549.31 |
| 83721 |
|
1,737 |
1,180 |
$533.80 |
| 84100 |
|
5,432 |
3,387 |
$518.16 |
| 87481 |
|
713 |
486 |
$505.92 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
263 |
176 |
$503.84 |
| 87653 |
|
716 |
494 |
$490.17 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$486.99 |
| 85730 |
|
3,331 |
2,165 |
$474.02 |
| 86480 |
|
23 |
23 |
$468.58 |
| 87324 |
|
884 |
637 |
$468.43 |
| 87640 |
|
696 |
477 |
$417.20 |
| 87493 |
|
2,430 |
1,527 |
$408.34 |
| 82550 |
|
1,071 |
529 |
$343.93 |
| 85044 |
|
3,477 |
2,326 |
$279.35 |
| 85379 |
|
489 |
302 |
$247.41 |
| 87449 |
|
1,087 |
800 |
$239.43 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
447 |
209 |
$221.40 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
15 |
$208.34 |
| 81015 |
|
11,839 |
7,875 |
$194.34 |
| 83690 |
|
896 |
566 |
$190.78 |
| 82043 |
|
2,063 |
1,440 |
$163.40 |
| 82570 |
|
1,020 |
674 |
$162.26 |
| 87076 |
|
1,415 |
587 |
$151.19 |
| 86141 |
|
38 |
27 |
$130.37 |
| 80050 |
General health panel |
133 |
127 |
$120.20 |
| 84154 |
|
103 |
77 |
$117.81 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
125 |
95 |
$96.18 |
| 84145 |
|
687 |
450 |
$89.23 |
| 86769 |
|
163 |
98 |
$85.28 |
| 87634 |
|
19 |
14 |
$68.80 |
| 86038 |
|
74 |
51 |
$68.54 |
| 84450 |
|
505 |
317 |
$63.38 |
| 84520 |
|
232 |
127 |
$59.56 |
| 80188 |
|
40 |
28 |
$58.79 |
| 82150 |
|
415 |
265 |
$54.35 |
| 83090 |
|
202 |
157 |
$31.89 |
| 87177 |
|
96 |
65 |
$26.24 |
| 86328 |
|
152 |
94 |
$26.20 |
| 80175 |
|
37 |
27 |
$25.96 |
| 82947 |
|
66 |
43 |
$24.68 |
| 86592 |
|
16 |
16 |
$23.80 |
| 85008 |
|
1,388 |
782 |
$19.41 |
| 86361 |
|
16 |
12 |
$19.22 |
| 84156 |
|
128 |
88 |
$17.86 |
| 82378 |
|
35 |
24 |
$14.22 |
| 83615 |
|
146 |
89 |
$12.06 |
| 85007 |
|
231 |
154 |
$9.01 |
| 82310 |
|
41 |
27 |
$8.71 |
| 83605 |
|
53 |
38 |
$6.25 |
| 82465 |
|
18 |
12 |
$2.63 |
| 82272 |
|
79 |
52 |
$2.57 |
| 80150 |
|
96 |
25 |
$0.00 |
| 84155 |
|
37 |
25 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
32 |
25 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
112 |
100 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
20 |
13 |
$0.00 |